BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Modak JK, Liu YC, Supuran CT, Roujeinikova A. Structure-Activity Relationship for Sulfonamide Inhibition of Helicobacter pylori α-Carbonic Anhydrase. J Med Chem 2016;59:11098-109. [PMID: 28002963 DOI: 10.1021/acs.jmedchem.6b01333] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Del Prete S, Vullo D, Osman SM, AlOthman Z, Donald WA, Winum JY, Supuran CT, Capasso C. Anion inhibitors of the β-carbonic anhydrase from the pathogenic bacterium responsible of tularemia, Francisella tularensis. Bioorg Med Chem 2017;25:4800-4. [PMID: 28754318 DOI: 10.1016/j.bmc.2017.07.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
2 Zolfaghari Emameh R, Masoori L, Taheri RA, Falak R. Identification and characterization of parvalbumin-like protein in Trichophyton violaceum. Fungal Biol 2020;124:592-600. [PMID: 32448450 DOI: 10.1016/j.funbio.2020.02.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Liu Q, Ni W, Li Z, Bai C, Tan D, Pu C, Zhou D, Tian Q, Luo N, Tan K, Dai L, Yan Y, Pei Y, Li X, Xiao Z, Zhu H. Resolution and evaluation of 3-chlorophenyl-3-hydroxypropionylhydroxamic acid as antivirulence agent with excellent eradication efficacy in Helicobacter pylori infected mice. European Journal of Pharmaceutical Sciences 2018;121:293-300. [DOI: 10.1016/j.ejps.2018.05.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Campestre C, De Luca V, Carradori S, Grande R, Carginale V, Scaloni A, Supuran CT, Capasso C. Carbonic Anhydrases: New Perspectives on Protein Functional Role and Inhibition in Helicobacter pylori. Front Microbiol 2021;12:629163. [PMID: 33815311 DOI: 10.3389/fmicb.2021.629163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Abutaleb NS, Elhassanny AEM, Nocentini A, Hewitt CS, Elkashif A, Cooper BR, Supuran CT, Seleem MN, Flaherty DP. Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae. J Enzyme Inhib Med Chem 2022;37:51-61. [PMID: 34894972 DOI: 10.1080/14756366.2021.1991336] [Reference Citation Analysis]
6 Supuran CT, Capasso C. An Overview of the Bacterial Carbonic Anhydrases. Metabolites 2017;7:E56. [PMID: 29137134 DOI: 10.3390/metabo7040056] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 17.4] [Reference Citation Analysis]
7 Vullo D, Del Prete S, Di Fonzo P, Carginale V, Donald WA, Supuran CT, Capasso C. Comparison of the Sulfonamide Inhibition Profiles of the β- and γ-Carbonic Anhydrases from the Pathogenic Bacterium Burkholderia pseudomallei. Molecules 2017;22:E421. [PMID: 28272358 DOI: 10.3390/molecules22030421] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
8 Modak JK, Tikhomirova A, Gorrell RJ, Rahman MM, Kotsanas D, Korman TM, Garcia-Bustos J, Kwok T, Ferrero RL, Supuran CT, Roujeinikova A. Anti-Helicobacter pylori activity of ethoxzolamide. J Enzyme Inhib Med Chem 2019;34:1660-7. [PMID: 31530039 DOI: 10.1080/14756366.2019.1663416] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
9 Artier J, Holland SC, Miller NT, Zhang M, Burnap RL. Synthetic DNA system for structure-function studies of the high affinity CO2 uptake NDH-13 protein complex in cyanobacteria. Biochimica et Biophysica Acta (BBA) - Bioenergetics 2018;1859:1108-18. [DOI: 10.1016/j.bbabio.2018.06.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
10 Abdoli M, Bozdag M, Angeli A, Supuran CT. Benzamide-4-Sulfonamides Are Effective Human Carbonic Anhydrase I, II, VII, and IX Inhibitors. Metabolites 2018;8:E37. [PMID: 29857578 DOI: 10.3390/metabo8020037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Angeli A, Ferraroni M, Supuran CT. Famotidine, an Antiulcer Agent, Strongly Inhibits Helicobacter pylori and Human Carbonic Anhydrases. ACS Med Chem Lett 2018;9:1035-8. [PMID: 30344913 DOI: 10.1021/acsmedchemlett.8b00334] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
12 Rahman MM, Tikhomirova A, Modak JK, Hutton ML, Supuran CT, Roujeinikova A. Antibacterial activity of ethoxzolamide against Helicobacter pylori strains SS1 and 26695. Gut Pathog 2020;12:20. [PMID: 32318117 DOI: 10.1186/s13099-020-00358-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Supuran CT. Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. Expert Opin Drug Discov 2020;15:671-86. [PMID: 32208982 DOI: 10.1080/17460441.2020.1743676] [Cited by in Crossref: 25] [Cited by in F6Publishing: 41] [Article Influence: 12.5] [Reference Citation Analysis]
14 Nocentini A, Hewitt CS, Mastrolorenzo MD, Flaherty DP, Supuran CT. Anion inhibition studies of the α-carbonic anhydrases from Neisseria gonorrhoeae. J Enzyme Inhib Med Chem 2021;36:1061-6. [PMID: 34030562 DOI: 10.1080/14756366.2021.1929202] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Ali M, Angeli A, Bozdag M, Carta F, Capasso C, Farooq U, Supuran CT. Benzylaminoethylureido-Tailed Benzenesulfonamides Show Potent Inhibitory Activity against Bacterial Carbonic Anhydrases. ChemMedChem 2020;15:2444-7. [PMID: 32966693 DOI: 10.1002/cmdc.202000680] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Angeli A, Del Prete S, Osman SM, Alasmary FAS, AlOthman Z, Donald WA, Capasso C, Supuran CT. Activation studies of the α- and β-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae with amines and amino acids. J Enzyme Inhib Med Chem 2018;33:227-33. [PMID: 29231751 DOI: 10.1080/14756366.2017.1412316] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
17 Salillas S, Sancho J. Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens. Int J Mol Sci 2020;21:E1881. [PMID: 32164177 DOI: 10.3390/ijms21051881] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Vullo D, Kumar RSS, Scozzafava A, Ferry JG, Supuran CT. Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens. J Enzyme Inhib Med Chem 2018;33:31-6. [PMID: 29098923 DOI: 10.1080/14756366.2017.1388233] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
19 Kaur J, Cao X, Abutaleb NS, Elkashif A, Graboski AL, Krabill AD, AbdelKhalek AH, An W, Bhardwaj A, Seleem MN, Flaherty DP. Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus. J Med Chem 2020;63:9540-62. [PMID: 32787141 DOI: 10.1021/acs.jmedchem.0c00734] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
20 Ronci M, Del Prete S, Puca V, Carradori S, Carginale V, Muraro R, Mincione G, Aceto A, Sisto F, Supuran CT, Grande R, Capasso C. Identification and characterization of the α-CA in the outer membrane vesicles produced by Helicobacter pylori. J Enzyme Inhib Med Chem 2019;34:189-95. [PMID: 30734607 DOI: 10.1080/14756366.2018.1539716] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
21 Del Prete S, Vullo D, Osman SM, Alothman Z, Supuran CT, Capasso C. Sulfonamide inhibition profiles of the β-carbonic anhydrase from the pathogenic bacterium Francisella tularensis responsible of the febrile illness tularemia. Bioorganic & Medicinal Chemistry 2017;25:3555-61. [DOI: 10.1016/j.bmc.2017.05.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
22 Flaherty DP, Seleem MN, Supuran CT. Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets. Future Med Chem 2021. [PMID: 34382415 DOI: 10.4155/fmc-2021-0207] [Reference Citation Analysis]
23 Supuran CT, Capasso C. Biomedical applications of prokaryotic carbonic anhydrases. Expert Opin Ther Pat 2018;28:745-54. [PMID: 29973089 DOI: 10.1080/13543776.2018.1497161] [Cited by in Crossref: 38] [Cited by in F6Publishing: 46] [Article Influence: 9.5] [Reference Citation Analysis]
24 Berrino E, Supuran CT. Novel approaches for designing drugs that interfere with pH regulation. Expert Opin Drug Discov 2019;14:231-48. [PMID: 30681011 DOI: 10.1080/17460441.2019.1567488] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
25 da Rosa R, Zimmermann LA, de Moraes MH, Schneider NFZ, Schappo AD, Simões CMDO, Steindel M, Schenkel EP, Bernardes LSC. Synthesis and biological evaluation of isoxazolyl-sulfonamides: A non-cytotoxic scaffold active against Trypanosoma cruzi, Leishmania amazonensis and Herpes Simplex Virus. Bioorganic & Medicinal Chemistry Letters 2018;28:3381-4. [DOI: 10.1016/j.bmcl.2018.08.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
26 Urbanski LJ, Vullo D, Parkkila S, Supuran CT. An anion and small molecule inhibition study of the β-carbonic anhydrase from Staphylococcus aureus. J Enzyme Inhib Med Chem 2021;36:1088-92. [PMID: 34056990 DOI: 10.1080/14756366.2021.1931863] [Reference Citation Analysis]
27 Yu J, Jia H, Guo X, Desta S, Zhang S, Zhang J, Ding X, Liang X, Liu X, Zhan P. Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non‐nucleoside hepatitis B virus inhibitors by exploring the solvent‐exposed region. Chem Biol Drug Des 2020;95:567-83. [DOI: 10.1111/cbdd.13512] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
28 Grande R, Carradori S, Puca V, Vitale I, Angeli A, Nocentini A, Bonardi A, Gratteri P, Lanuti P, Bologna G, Simeone P, Capasso C, De Luca V, Supuran CT. Selective Inhibition of Helicobacter pylori Carbonic Anhydrases by Carvacrol and Thymol Could Impair Biofilm Production and the Release of Outer Membrane Vesicles. Int J Mol Sci 2021;22:11583. [PMID: 34769015 DOI: 10.3390/ijms222111583] [Reference Citation Analysis]
29 Mohamed MA, Abdel-aziz AA, Sakr HM, El-azab AS, Bua S, Supuran CT. Synthesis and human/bacterial carbonic anhydrase inhibition with a series of sulfonamides incorporating phthalimido moieties. Bioorganic & Medicinal Chemistry 2017;25:2524-9. [DOI: 10.1016/j.bmc.2017.03.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
30 Annunziato G, Giovati L, Angeli A, Pavone M, Del Prete S, Pieroni M, Capasso C, Bruno A, Conti S, Magliani W, Supuran CT, Costantino G. Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases. J Enzyme Inhib Med Chem 2018;33:1537-44. [PMID: 30284487 DOI: 10.1080/14756366.2018.1516652] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]